Los Angeles and Duarte, Calif.; Atlanta, Ga.; and Boston, Mass.
From the Division of Plastic Surgery, Departments of Epidemiology and Pathology, Keck School of Medicine at the University of Southern California; the Division of Oncology and Hematology, David Geffen School of Medicine at the University of California, Los Angeles; the Division of Plastic Surgery, Emory University School of Medicine; City of Hope Cancer Hospital.
Received for publication July 16, 2014; accepted August 28, 2014.
Disclosure: There was no personal funding for any of the authors other than to contract the services of Ms. House-Lightner from the Department of Preventive Medicine. Dr. Brody received no personal remuneration and was compensated only for travel expenses to meetings where he presented this work, including a five-city tour of Australia and New Zealand to inform the local plastic surgeons about ALCL at Allergan’s invitation. The tissue culture work by Dr. Epstein was supported by Mentor Corp. (Santa Barbara, Calif.), Allergan, Inc. (San Diego, Calif.), and Cancer Therapeutics Laboratories, Inc. (Los Angeles, Calif.), of which Dr. Epstein and Dr. Taylor are cofounders. None of the other authors has received any personal remuneration or has any conflict of interest.
This work was supported by THE PLASTIC SURGERY FOUNDATION.
Garry S. Brody, M.D., M.Sc., Division of Plastic Surgery, Keck School of Medicine, University of Southern California, 1510 San Pablo St., #415, Los Angeles, Calif. 90033, gsbmd@aol.com
